Commercialization of a Biologic Product to Reduce Lyme Disease in the Environment

What do you do if your novel pest control method does not fit into any of the existing regulatory buckets? As regulatory bodies become more aware of the need to acknowledge indirect effects of pest control methods, effective and environmentally sensitive approaches, like IPM, will become more relevant. Dr. John Brooke will discuss specifically the recent commercialization of a wildlife biologic against Lyme disease and generally how companies with a breakthrough technology can unexpectedly struggle.
This is the 2nd webinar in a series leading up to the 11th International IPM Symposium held March 3-6, 2025 in San Diego, California.